News
The BiVACOR THA hooked up with the CTO Dianiel Timms in the background. (Credit: BiVACOR) Outside of the brain, the heart is probably the organ that you miss the most when it ceases to function ...
Bivacor's Total Artificial Heart gets FDA Breakthrough Device status, speeding development and possibly transforming heart-failure treatment. Houston Business Journal Select a City ...
The BiVACOR heart could help address this crisis by replacing human heart transplants - perhaps in a decade. More engineering is needed including how to power the device more conveniently.
BiVACOR's Total Artificial Heart is not your average mechanical heart. It employs the same magnetic levitation technology used in high-speed rail lines, creating a frictionless environment for its ...
Australian company BiVACOR has revealed a patient implanted with its artificial heart survived for 100 days – and is still with us after receiving a donated organ.… The un-named man had heart ...
The grant is matched by in-kind support bringing approximately AUD$2.2 million in funding for BiVACOR’s clinical advancement BiVACOR is an Australian-born innovation, and we are extremely ...
HUNTINGTON BEACH, Calif., December 18, 2024--The five-patient FDA Early Feasibility Study of BiVACOR Total Artificial Heart successfully bridges all to a donor heart transplant-EFS expanded to 15 ...
BiVACOR®, a clinical-stage medical device company, today announced $13 million (USD) awarded from the Australian Government’s Medical Research Future Fund (M ...
The US Food and Drug Administration (FDA) has granted an investigational device exemption (IDE) to BiVACOR’s total artificial heart (BTAH), greenlighting the way for an early feasibility study ...
BiVACOR was founded in 2008 by a team of internationally renowned biomedical engineers and cardiac surgeons, including Founder and Chief Technical Officer Daniel Timms, Ph.D., ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results